Be in the know. 20 key reads for Monday…

  1. Gilead raises 2020 profit forecast on remdesivir strength (CNBC)
  2. Exxon Mobil upgraded to Overweight from Equal Weight at Morgan Stanley (TheFly)
  3. Biden’s Big Decision on Tech Taxes (Wall Street Journal)
  4. Covid-19 Vaccine Rollout Goes Smoothly in Connecticut (Wall Street Journal)
  5. Stock market exuberance is here to stay, Credit Suisse says. Here’s why investors can be positive (MarketWatch)
  6. JPMorgan Chase, Wells Fargo, Delta, TSMC, and Other Stocks to Watch This Week (Barron’s)
  7. ‘Prepare to lose all your money’ — regulator’s blunt warning on bitcoin and other cryptocurrencies (MarketWatch)
  8. Earnings Season Is About to Begin. What to Expect. (Barron’s)
  9. Nearly $170 billion wiped off cryptocurrency market in 24 hours as bitcoin pulls back (CNBC)
  10. Twitter Shares Under Pressure After Ban on Trump’s Account (Barron’s)
  11. Wall Street analysts are cautiously optimistic on J&J’s ‘one-dose’ Covid vaccine (CNBC)
  12. Goldman, JPMorgan, Citi Suspend Political Donations (Bloomberg)
  13. Trump’s social media bans are raising new questions on tech regulation (CNBC)
  14. Pickup trucks dominate America’s 10 best-selling vehicles of 2020 (CNBC)
  15. Gene-Therapy Firm Bluebird Bio Is Spinning Off Its Cancer Programs (Bloomberg)
  16. Moderna to develop vaccine candidates for seasonal flu, HIV (MarketWatch)
  17. BioNTech to target supply of up to 2 billion doses of COVID-19 vaccine in 2021 (MarketWatch)
  18. Israel Plans to Vaccinate Everyone by March. Here’s How. (Wall Street Journal)
  19. Ban on Chinese Stocks Roils Investors (Wall Street Journal)
  20. Barron’s Picks And Pans: Dividend Aristocrats, Alibaba, GameStop, Walmart And More (Yahoo! Finance)